Table 1 Clinicopathologic characteristics of the colon cancer patients
From: Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer
Parameters | No. of patients(%) | Parameters | No. of patients(%) |
|---|---|---|---|
Age (median, 59 years) | Â | N2 | 13(11.4) |
< 59 | 48(42.1) | Recurrence/distant metastasis | Â |
≥ 59 | 66(57.9) | Yes | 23(20.0) |
Gender | Â | No | 91(79.8) |
Men | 54(47.4) | L/infiltrationa | Â |
Women | 60(52.6) | Yes | 41(36.0) |
Tumor size(average 5.0) | Â | No | 73(64.0) |
< 5.0 | 52 (45.6) | depth of invasion | Â |
≥ 5.0 | 62(54.4) | T2 | 15(13.2) |
Localization | Â | T3 | 88(77.2) |
colon ascendens | 27(23.7) | T4 | 11 (9.6) |
flexura hepatica | 22(19.3) | Distant metastasis | Â |
colon transversum | 6(5.3) | M0 | 102(89.5) |
flexura lienalis | 8(7.0) | M1 | 12 (10.5) |
colon descendens | 6(5.3) | TNM staging | Â |
colon sigmoideum | 45 (39.5) | I | 11(9.6) |
Tumor differentiation | Â | II | 47(41.2) |
low | 16(14.0) | III | 44(38.6) |
moderate | 68(59.6) | IV | 12(10.5) |
high | 30(26.3) | Clinical outcome | Â |
Lymph node metastasis | Â | Disease free | 72(63.2) |
N0 | 65(57.0) | Metastasis or recurrence | 72(63.2) |
N1 | 36(31.6) | Death | 42(36.8) |